A drug developed as an antidote to the antiplatelet agent ticagrelor safely and effectively reversed ticagrelor's antiplatelet effects in patients undergoing urgent surgery or experiencing major ...

The 30-day mortality rate after emergent abdominal surgery is twice as high for patients on dialysis who experience major bleeding. Patients on dialysis experience high rates of bleeding requiring ...

Bentracimab effectively reversed ticagrelor's antiplatelet effects, restoring platelet function in minutes for most patients in urgent situations. The REVERSE-IT trial showed 94.3% of patients ...

Improving Global Outcomes recommendations reduced moderate or severe AKI risk after major surgery, according to data ...

Cryopreserved platelets cost more and are linked to worse bleeding and clinical outcomes than liquid-stored platelets in a ...

A protocol of KDIGO-recommended strategies in high-risk patients significantly reduces moderate-to-severe acute kidney injury ...

In patients undergoing revascularization for left main coronary artery disease, CABG is associated with higher rates of all bleeds and in-hospital major bleeding, while PCI is linked to more ...

The BigpAK-2 randomized prospective multicenter trial tested implementation of a bundle of measures to prevent acute kidney injury in high-risk patients undergoing major surgery. Trial results support ...

Apixaban 2.5 mg twice daily significantly reduced symptomatic venous thromboembolism (VTE) recurrence, with a low risk of major bleeding, in patients with provoked VTE and enduring risk factors, ...

Please provide your email address to receive an email when new articles are posted on . Bentracimab restored platelet function in patients on ticagrelor with major bleeding or undergoing urgent ...

The appropriate duration of anticoagulation for venous thromboembolism (VTE) in patients who have a transient provoking factor (e.g., surgery, trauma, or immobility) and concomitant enduring risk ...

Removing 10 per cent of a patient’s blood before major liver surgery and giving it back afterwards reduced transfusions by half, according to a large clinical trial published in The Lancet ...